MASTERS - International distributors of pharmaceuticals

News for partnerships

Partnership News

BiCNU - Masters working in partnership with Emcure

Masters Pharmaceuticals Limited is pleased to announce its partnership with Emcure Pharmaceuticals Limited. The agreement, commencing 29^th  April, 2013, will enable patients and healthcare professionals in the Caribbean, Middle East, Africa and Latin America to access BiCNU^®  (INN: Carmustine for injection). 

Healthcare Distribution Management Association (HDMA)

Masters Medical Inc (MMI) based in Florida is pleased to announce that it has become a member of the Healthcare Distribution Management Association (HDMA). This affliliation will provide additional resource to further strengthen the Masters supply chain and enhance the services we provide to our valued customers.

Masters, focused on providing the Patient, wherever they are, access to the best available treatments.

 
  
Master . . ,

Systemic Mastocytosis and Mast Cell Activation Syndrome - sodium cromoglicate 100mg Tablets

Masters Pharmaceuticals Ltd is pleased to announce the availability of sodium cromoglicate 100mg Tablets for the alleviation of the symptoms of Systemic Mastocytosis and Mast Cell Activation Syndrome.
Please see the information below regarding supply:

LORAZEPAM Injection 4mg/ml - Available from Masters Pharmaceuticals Limited.

Masters Pharmaceuticals Limited in the United Kingdom is pleased to announce the availability of Lorazepam Injection 4mg/mL.

Presentation: Lorazepam Injection 4mg/mL is supplied as 1mL vials in packs of 25